F25.2

ICD-10 diagnosis F25.2 refers to a specific subtype of schizoaffective disorder characterized by mixed symptoms of schizophrenia and mood disturbances that do not clearly fall under depressive or manic subtypes. This diagnosis is relatively rare and can be challenging to identify due to its overlapping clinical features.

The diagnosis requires:

• Prominent symptoms of both schizophrenia and mood disorders occurring within the same episode of illness
• Mood symptoms meeting criteria for both manic and depressive episodes, either simultaneously or alternating

Clinical features and symptoms

Schizoaffective disorder, mixed type (F25.2), involves a complex interplay of psychotic and mood-related symptoms.

The key features include:

Psychotic symptoms

1. Hallucinations:
   • Auditory hallucinations, such as hearing voices that provide running commentary, argue, or give commands.
   • Visual or tactile hallucinations, though less common, may also occur.
2. Delusions:
   • Fixed false beliefs, such as persecutory, grandiose, or bizarre delusions.
   • Often inconsistent with mood disturbances, which distinguishes this disorder from mood disorders with psychotic features.
3. Disorganized thinking:
   • Speech may show loose associations, tangentiality, or incoherence.
4. Negative symptoms:
   • Reduced emotional expression, avolition (lack of motivation), and social withdrawal may coexist with mood-related symptoms.

Mood symptoms

1. Manic symptoms:
   • Elevated or irritable mood, increased energy, grandiosity, decreased need for sleep, and impulsivity.
2. Depressive symptoms:
   • Low mood, anhedonia, fatigue, feelings of guilt or worthlessness, psychomotor changes, and suicidal ideation.
3. Mixed mood states:
   • Simultaneous presence of manic and depressive symptoms, creating diagnostic complexity.

Diagnostic Criteria

Schizophrenic component

Must include at least two of the following:

1. Delusions
2. Hallucinations
3. Disorganized speech
4. Grossly disorganized or catatonic behavior
5. Negative symptoms

Mood component

Must demonstrate:

1. Manic episodes with:

• Elevated, expansive, or irritable mood
• Increased energy and activity
• Racing thoughts
• Grandiosity
• Decreased need for sleep
• Engaging excessively in enjoyable pursuits

2. Depressive episodes with:

• Depressed mood
• Loss of interest or pleasure
• Decrease in sleep
• Psychomotor changes
• Fatigue
• Feelings of worthlessness
• Diminished concentration
• Suicidal ideation

To meet the criteria for F25.2, the following must be observed:

1. Concurrent psychotic and mood symptoms:
   • Symptoms of schizophrenia (e.g., delusions, hallucinations) must occur simultaneously with prominent mood symptoms (both manic and depressive).
2. Duration of symptoms:
   • Psychotic symptoms must persist for at least two weeks without significant mood symptoms, distinguishing schizoaffective disorder from mood disorders with psychotic features.
3. Functional impairment:
   • Marked decline in social, occupational, or academic functioning due to symptoms.
4. Exclusion of other conditions:
   • Symptoms must not be better explained by substance use, medication side effects, or another medical condition.

Functional impact:

• Occupational and social functioning typically more impaired during psychotic episodes
• Level of functioning may fluctuate with mood states
• Generally better prognosis than schizophrenia but worse than pure mood disorders

Differential diagnosis

Bipolar disorder with psychotic features

• Ongoing psychotic symptoms occurring independently of mood episodes
• Nature and quality of psychotic symptoms
• Family history and longitudinal course

• • Differentiation: Psychotic features in bipolar disorder occur only during mood episodes, whereas in F25.2, psychotic symptoms may persist independently.

Major depressive disorder with psychotic features

• Presence of manic symptoms
• Duration and character of psychotic symptoms
• Response to treatment

• • Differentiation: In major depression, psychosis is mood-congruent and limited to depressive episodes, unlike F25.2.

Schizophrenia

• Prominence and duration of mood symptoms
• Temporal relationship between psychotic and affective symptoms
• Better premorbid functioning in schizoaffective disorder

• • Differentiation: Schizophrenia lacks prominent mood symptoms, which are defining in F25.2.

Substance-induced psychotic disorder

• Temporal relationship to substance use
• Resolution of symptoms with abstinence
• Nature of symptoms
  • Differentiation: Symptoms resolve after cessation of substance use, unlike in F25.2.

Borderline personality disorder (F60.3)

• Differentiation: While mood instability is common, the structured, persistent nature of delusions and hallucinations in schizoaffective disorder sets it apart.

Delusional Disorder (F22)

• Differentiation: Characterized by delusions without the disorganization or negative symptoms typical of schizophrenia or schizoaffective disorder.

Neurological or medical disorders

• Rule out conditions such as temporal lobe epilepsy, CNS infections, or endocrine disorders.

Differential diagnosis between schizoaffective subtypes

F25.0 Schizoaffective Disorder, Manic Type

Distinguishing features:

• Only manic episodes occur alongside schizophrenic symptoms
• No history of major depressive episodes

Characteristic presentation:

• Elevated mood and increased energy predominate
• Grandiosity often combines with schizophrenic delusions
• More likely to show aggressive or agitated behavior
• Higher risk of impulsive actions and poor judgment
• Better short-term prognosis than depressive type

F25.1 Schizoaffective disorder, depressive type

Distinguishing features:

• Only depressive episodes occur alongside schizophrenic symptoms
• No history of manic episodes

Characteristic presentation:

• Depressive symptoms coincide with psychotic features
• Higher risk of suicide compared to other subtypes
• More likely to show negative symptoms
• Often presents with mood-congruent delusions
• May have more prominent cognitive impairment

F25.2 Schizoaffective disorder, mixed type

Distinguishing features:

• Both manic and depressive episodes occur with schizophrenic symptoms
• More complex clinical course than single-polarity types

Characteristic presentation:

• Mood symptoms may alternate or occur simultaneously
• More variable symptom patterns
• Can show rapid cycling between mood states
• Generally more challenging to treat
• May require more complex medication regimens

Key differential points

1. Temporal pattern

• F25.0: Manic episodes synchronous with psychotic symptoms
• F25.1: Depressive episodes synchronous with psychotic symptoms
• F25.2: Both types of mood episodes present during illness course

2. Treatment response

• F25.0: Often responds to combination of antipsychotics and antimanic agents
• F25.1: May require antidepressants with careful monitoring
• F25.2: Usually needs mood stabilizers targeting both poles

3. Risk assessment

• F25.0: Higher risk of manic-driven dangerous behavior
• F25.1: Higher risk of suicide and self-harm
• F25.2: Complex risk profile requiring careful monitoring of both poles

4. Course predictors

• F25.0: Better functional recovery during non-manic periods
• F25.1: More chronic course with residual symptoms
• F25.2: More variable course with multiple episode types

Diagnostic evaluation

Clinical assessment

1. Detailed History:
   • Include onset, duration, and progression of symptoms.
   • Check the family history if there were possible psychiatric disorders.
2. Mental Status Examination (MSE):
   • Evaluate thought content, perception, mood, affect, and cognitive function.
3. Functional Assessment:
   • Measure the impact of symptoms on daily life and relationships.

Laboratory and imaging studies

1. Basic Tests:
   • Complete blood count (CBC), thyroid function tests, and metabolic panel to rule out systemic causes.
2. Drug Screening:
   • Exclude substance-induced psychosis.
3. Neuroimaging:
   • Brain MRI or CT may help rule out structural abnormalities.
4. Electroencephalogram (EEG):
   • To exclude seizure disorders presenting with psychosis.

Psychometric tools

1. Positive and Negative Syndrome Scale (PANSS).
2. Young Mania Rating Scale (YMRS).
3. Hamilton Depression Rating Scale (HAM-D).

Diagnostic challenges

1. Temporal overlap

• Difficulty determining if psychotic symptoms are mood-congruent or independent
• Challenge in establishing temporal relationship between mood and psychotic symptoms

2. Symptom attribution

• Complex interaction between affective and psychotic symptoms
• Variable presentation over time

3. Historical information

• Often incomplete or unreliable
• Need for multiple sources of information

Treatment

Management of F25.2 involves a combination of pharmacological and psychosocial interventions:

Pharmacological treatment:

1. Antipsychotics:
   • Atypical antipsychotics (e.g., risperidone, olanzapine, aripiprazole) for psychotic symptoms.
2. Mood Stabilizers:
   • Lithium or valproate to address manic or mixed states.
3. Antidepressants:
   • Selective serotonin reuptake inhibitors (SSRIs) for depressive symptoms (used cautiously to avoid triggering mania).

Psychosocial interventions:

1. Cognitive Behavioral Therapy (CBT):
   • To address delusions, mood symptoms, and functional impairments.
2. Family Therapy:
   • Educate family members about the disorder and strategies for support.
3. Rehabilitation Programs:
   • Vocational and social skills training to enhance daily functioning.
4. Support Groups:
   • Participation in peer-led groups for shared experiences and coping strategies.

Prognosis

The prognosis for F25.2 varies depending on early diagnosis, treatment adherence, and comorbid conditions. While some individuals achieve significant symptom control, others may experience chronic functional impairments.

Sources:

1. World Health Organization. (2019) International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10): F25.2 Schizoaffective disorder, mixed type. Geneva: WHO. Available at: https://icd.who.int/browse10/2019/en#/F25.2 .
2. American Psychiatric Association. (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5). Arlington, VA: American Psychiatric Publishing.
3. Marneros, A. & Tsuang, M.T. (2016) Schizoaffective Disorders. Cambridge: Cambridge University Press.
4. Cheniaux, E., Landeira-Fernandez, J., Telles, L.L., et al. (2008) Does schizoaffective disorder really exist? A systematic review of the literature. Acta Psychiatrica Scandinavica, 118(6), pp. 395–402. doi:10.1111/j.1600-0447.2008.01267.x.
5. National Alliance on Mental Illness (NAMI). (2024) Schizoaffective disorder. Available at: https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Schizoaffective-Disorder .
6. Mayo Clinic. (2024) Schizoaffective disorder: Symptoms and causes. Available at: https://www.mayoclinic.org/diseases-conditions/schizoaffective-disorder/symptoms-causes/syc-20354504 .
7. Medscape. (2024) Schizoaffective disorder clinical presentation. Available at: https://emedicine.medscape.com/article/294763-clinical .
8. StatPearls. (2024) Schizoaffective Disorder. Available at: https://www.ncbi.nlm.nih.gov/books/NBK539857/ .
9. Mental Health UK. (2024) Schizoaffective disorder. Available at: https://mentalhealth-uk.org/help-and-information/conditions/schizoaffective-disorder/ .